These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16999839)
1. Breakthrough pain in opioid-treated chronic non-malignant pain patients referred to a multidisciplinary pain centre: a preliminary study. Højsted J; Nielsen PR; Eriksen J; Hansen OB; Sjøgren P Acta Anaesthesiol Scand; 2006 Nov; 50(10):1290-6. PubMed ID: 16999839 [TBL] [Abstract][Full Text] [Related]
2. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
3. Pain management of opioid-treated cancer patients in hospital settings in Denmark. Lundorff L; Peuckmann V; Sjøgren P Acta Anaesthesiol Scand; 2008 Jan; 52(1):137-42. PubMed ID: 18005379 [TBL] [Abstract][Full Text] [Related]
4. Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain centre. Sjøgren P; Christrup LL; Petersen MA; Højsted J Eur J Pain; 2005 Aug; 9(4):453-62. PubMed ID: 15979026 [TBL] [Abstract][Full Text] [Related]
5. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. Jensen MK; Thomsen AB; Højsted J Eur J Pain; 2006 Jul; 10(5):423-33. PubMed ID: 16054407 [TBL] [Abstract][Full Text] [Related]
6. Breakthrough pain in the management of chronic persistent pain syndromes. Webster LR Am J Manag Care; 2008 May; 14(5 Suppl 1):S116-22. PubMed ID: 18611099 [TBL] [Abstract][Full Text] [Related]
8. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ). Taylor DR; Webster LR; Chun SY; Reinking J; Stegman M; Shoemaker S; Fortner B Pain Med; 2007 Apr; 8(3):281-8. PubMed ID: 17371416 [TBL] [Abstract][Full Text] [Related]
9. [Opioids for chronic pain patients. What are the consequences of following the Nordic recommendations?]. Handberg G; Bendiksen A; McGehee E; Vrads R Ugeskr Laeger; 2007 Oct; 169(41):3486-8. PubMed ID: 17967279 [TBL] [Abstract][Full Text] [Related]
10. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain. Slatkin NE; Xie F; Messina J; Segal TJ J Support Oncol; 2007; 5(7):327-34. PubMed ID: 17708123 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717 [TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapeutic management of breakthrough pain in patients with chronic persistent pain. Fishbain DA Am J Manag Care; 2008 May; 14(5 Suppl 1):S123-8. PubMed ID: 18611100 [TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Portenoy RK; Taylor D; Messina J; Tremmel L Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563 [TBL] [Abstract][Full Text] [Related]
14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
15. Breakthrough pain in patients referred to pain clinics: the Italian pain network retrospective study. Gatti A; Mediati RD; Reale C; Cuomo A; Vellucci R; Russo G; Costantini A; Canneti A; Luzi M; Mammucari M; Sabato AF Adv Ther; 2012 May; 29(5):464-72. PubMed ID: 22622488 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Manchikanti L; Manchikanti KN; Pampati V; Cash KA Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic results in chronic, non-malignant pain in patients treated at a Danish multidisciplinary pain center compared with general practice. A randomized controlled clinical trial]. Becker N; Sjøgren P; Olsen AK; Eriksen J Ugeskr Laeger; 2001 May; 163(22):3078-82. PubMed ID: 11449834 [TBL] [Abstract][Full Text] [Related]
18. [Pain epidemiology and health-related quality of life in patients with chronic non-malignant pain]. Becker N; Thomsen AB; Olsen AK; Sjøgren P; Bech P; Eriksen J Ugeskr Laeger; 1998 Nov; 160(47):6816-9. PubMed ID: 9835791 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386 [TBL] [Abstract][Full Text] [Related]
20. [Differences in the prescription of analgesics in the treatment of cancer pain in six Danish pain treatment units]. Olesen AE; Jarvig L; Hansen OB; Højsted J; Jensen NH; Jonsson T; Sjøgren P; Sonne NM; Sørensen JT; Christrup LL Ugeskr Laeger; 2007 May; 169(21):2024-9. PubMed ID: 17553385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]